Allogene Therapeutics ALLO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$42.61M-9.8% | -$38.81M+6.3% | -$41.4M+18.7% | -$50.94M+14.7% | -$59.73M+0.3% | ||
| $2.87M-6.1% | $3.06M-1.3% | $3.1M-0.3% | $3.11M+0.2% | $3.1M-4.1% | ||
| $8.27M+1.7% | $8.13M-6.0% | $8.65M-0.4% | $8.69M-28.7% | $12.18M-5.4% | ||
| -$12.91M+53.2% | -$27.6M+7.0% | -$29.69M+23.9% | -$39.03M+26.3% | -$52.93M-44.2% | ||
| $9K— | $0-100% | $243K+452% | $44K-55.6% | $99K-61.5% | ||
| -$29.59M-188% | $33.61M+182% | $11.94M-72.8% | $43.84M+610% | $6.18M-88.8% | ||
| $21.12M+169% | $7.86M+143% | $3.24M-36.2% | $5.07M-63.7% | $13.99M+144% | ||
| -$21.38M— | —— | -$14.52M— | —— | -$32.76M— | ||
| -$12.92M+53.2% | -$27.6M+7.8% | -$29.93M+23.4% | -$39.07M+26.3% | -$53.03M-43.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Allogene Therapeutics generate?
- Allogene Therapeutics (ALLO) generated -$109.2M in operating cash flow over the trailing twelve months.
- What is Allogene Therapeutics's free cash flow?
- After $296.0K of capital expenditures, Allogene Therapeutics's free cash flow was -$109.5M over the trailing twelve months, up 44.7% year over year.
- Where does Allogene Therapeutics's cash flow data come from?
- Every line is extracted from Allogene Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.